ArticleScience advances2026
Protein language models accurately predict polymorphic peptide-modulated NK cell receptor-HLA class I interaction strengths.
Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Killer-cell immunoglobulin-like receptors (KIRs) are key determinants of natural killer cell function and are associated with the outcomes of infective, inflammatory, and neoplastic diseases. They form a polymorphic family of activating and inhibitory receptors that interact with polymorphic class I human leukocyte antigen (HLA-I) molecules. This interaction is dependent on the short peptides bound by the HLA-I molecules, including those derived from viruses and cancers. Identifying these peptides among the vast space of possible peptides based on the sequences of the interacting molecules can provide a valuable tool for developing personalized immunotherapy against infection and cancer. To address this challenge, we leveraged foundation protein language models and trained our model on available datasets for KIR-binding peptide-HLA complexes. Our tool generated excellent predictions with an area under receiver operator characteristic (AUROC) >0.8 for the majority of inhibitory KIRs and performed well (AUROC >0.7) for peptides generated during HIV and HCV infections. Our model holds substantial potential for advancing our understanding of immune regulation and the biophysical factors responsible for it, paving the way for KIR-specific therapeutic interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.